Effects of GLP‐1 Receptor Agonist Therapy on Eating Disorder Risk and Psychological Distress in Adults With Class 3 Obesity
This study suggests that GLP1-RAs may not significantly worsen ED risk or psychological distress in adults with Class 3 obesity.
Authors
- Kathy Grudzinskas
- Suzanne Maynard (ORCID: https://orcid.org/0009-0005-6310-9243)
- Milan K. Piya (ORCID: https://orcid.org/0000-0002-2783-1168)
- Nic Kormas
- Pamela Acosta Reyes (ORCID: https://orcid.org/0000-0002-5106-6128)
- Phillipa Hay (ORCID: https://orcid.org/0000-0003-0296-6856)
- Ritesh Chimoriya (ORCID: https://orcid.org/0000-0003-1121-2829)
Institutions
- Camden and Campbelltown Hospitals (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- International Journal of Eating Disorders
- Published
- 2025-10-26
- DOI
- https://doi.org/10.1002/eat.24575
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00